JSW
RGEN icon

Journey Strategic Wealth’s Repligen RGEN Stock Holding History

Journey Strategic Wealth’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,565
Closed -$256K – 871
2025
Q4 		$256K Buy
+1,565
New +$245K 0.01% 577
2024
Q2 		– Sell
-1,187
Closed -$218K – 413
2024
Q1 		$218K Hold
1,187
– – 0.01% 264
2023
Q4 		$213K Buy
+1,187
New +$185K 0.01% 190
2023
Q2 		– Sell
-1,214
Closed -$204K – 258
2023
Q1 		$204K Sell
1,214
-40
-3% -$7.14K 0.02% 223
2022
Q4 		$212K Sell
1,254
-31
-2% -$5.62K 0.03% 205
2022
Q3 		$240K Buy
+1,285
New +$271K 0.03% 129
2022
Q2 		– Sell
-1,229
Closed -$231K – 193
2022
Q1 		$231K Buy
1,229
+170
+16% +$32.3K 0.03% 135
2021
Q4 		$280K Buy
+1,059
New +$285K 0.03% 129

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Journey Strategic Wealth's RGEN Position: Q1 2026 in Review

Journey Strategic Wealth sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,565 shares — an estimated $256K sold.

Journey Strategic Wealth first reported a position in RGEN in Q4 2021 and held it in 8 quarters. The position peaked at $280K in Q4 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Journey Strategic Wealth reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Journey Strategic Wealth sold 1,565 Repligen shares in Q1 2026, an estimated $256K.
  • Journey Strategic Wealth first reported a position in Repligen in Q4 2021 and held it in 8 quarters.
  • Journey Strategic Wealth's Repligen position peaked at $280K in Q4 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.